2024 Q3 Form 10-Q Financial Statement

#000173112224001287 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change -100.0%
Gross Profit $0.00 $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $228.3K $161.2K
YoY Change 553.76% 264.5%
Operating Profit -$228.3K -$161.2K
YoY Change 553.76% 237.06%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$291.8K -$225.2K
YoY Change 278.65% 150.98%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 64.37M shares 64.37M shares
Diluted Shares Outstanding 62.44M shares 62.38M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.452K $1.633K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $0.00 $150.0K
Prepaid Expenses $780.00 $1.560K
Receivables
Other Receivables
Total Short-Term Assets $2.232K $153.2K
YoY Change -98.96% -28.26%
LONG-TERM ASSETS
Property, Plant & Equipment $20.83K $21.80K
YoY Change -15.69% -15.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $20.83K $21.80K
YoY Change -15.69% -15.1%
TOTAL ASSETS
Total Short-Term Assets $2.232K $153.2K
Total Long-Term Assets $20.83K $21.80K
Total Assets $23.07K $175.0K
YoY Change -90.36% -26.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.276M $2.148M
YoY Change 16.95% 12.64%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.276M $2.148M
Total Long-Term Liabilities
Total Liabilities $2.276M $2.148M
YoY Change 16.95% 12.64%
SHAREHOLDERS EQUITY
Retained Earnings -$4.467M -$4.175M
YoY Change 35.44% 29.62%
Common Stock $64.87K $64.37K
YoY Change 17.22% 17.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.253M -$1.973M
YoY Change
Total Liabilities & Shareholders Equity $23.07K $175.0K
YoY Change -90.36% -26.84%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$291.8K -$225.2K
YoY Change 278.65% 150.98%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
161169 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
44216 usd
us-gaap Operating Expenses
OperatingExpenses
513938 usd
us-gaap Operating Expenses
OperatingExpenses
75375 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-161169 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-47816 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-513938 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-83055 usd
CY2024Q2 snbh Interest Expense Non Opearting
InterestExpenseNonOpearting
63985 usd
CY2023Q2 snbh Interest Expense Non Opearting
InterestExpenseNonOpearting
41895 usd
snbh Interest Expense Non Opearting
InterestExpenseNonOpearting
127970 usd
snbh Interest Expense Non Opearting
InterestExpenseNonOpearting
82501 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-225154 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-89711 usd
us-gaap Net Income Loss
NetIncomeLoss
-641908 usd
us-gaap Net Income Loss
NetIncomeLoss
-165556 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.004
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.004
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.002
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.011
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.011
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.003
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.003
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62380848 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62380848 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54580518 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54580518 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60260683 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60260683 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54520846 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54520846 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1933810 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
258000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-416754 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-2092564 usd
CY2024Q2 snbh Common Stock Issued In Payment Of Past Services
CommonStockIssuedInPaymentOfPastServices
14998 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
82750 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
179000 usd
CY2024Q2 snbh Conversion Of Note Payable And Accrued Interest Into Common Stock To Be Issued
ConversionOfNotePayableAndAccruedInterestIntoCommonStockToBeIssued
68054 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-225154 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1972916 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1642976 usd
CY2023Q1 snbh Common Stock Issued In Payment Of Past Services
CommonStockIssuedInPaymentOfPastServices
127000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13900 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-75845 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1577921 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-89711 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1667632 usd
us-gaap Net Income Loss
NetIncomeLoss
-641908 usd
us-gaap Net Income Loss
NetIncomeLoss
-165556 usd
us-gaap Depreciation
Depreciation
1938 usd
us-gaap Depreciation
Depreciation
1939 usd
snbh Common Stock Issued In Payments Of Past Services
CommonStockIssuedInPaymentsOfPastServices
14998 usd
snbh Common Stock Issued In Payments Of Past Services
CommonStockIssuedInPaymentsOfPastServices
127000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
340750 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
13900 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24539 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-6893 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2163 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-25615 usd
snbh Increase Decrease In Stock Subscription
IncreaseDecreaseInStockSubscription
85000 usd
snbh Increase Decrease In Stock Subscription
IncreaseDecreaseInStockSubscription
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-190166 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23793 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-0 usd
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
0 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
0 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
11500 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
22795 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
179000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
190500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22795 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
334 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-998 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1299 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1048 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1633 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50 usd
us-gaap Interest Paid Net
InterestPaidNet
79950 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
snbh Conversion Of Note Payable And Accrued Interests Into Common Stock To Be Issued
ConversionOfNotePayableAndAccruedInterestsIntoCommonStockToBeIssued
68054 usd
snbh Conversion Of Note Payable And Accrued Interests Into Common Stock To Be Issued
ConversionOfNotePayableAndAccruedInterestsIntoCommonStockToBeIssued
0 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4175288 usd
us-gaap Net Income Loss
NetIncomeLoss
-641908 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-190166 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zU0SVfn3T4G8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i><span id="xdx_865_zNfkJdzzCMEg">Uses of estimates in the preparation of financial statements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Inventory Write Down
InventoryWriteDown
63477 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
150000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
150000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
150000 usd
CY2024Q2 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
3272031 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
2000000 shares
CY2024Q2 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
68054 usd
CY2024Q2 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
3272031 shares
snbh Cash Payments And Shares Description
CashPaymentsAndSharesDescription
the Company engaged a consultant pursuant to which the consultant was to receive as consideration for services in accordance with a payment schedule three cash payments of $10,000 for a total of $30,000 and three issuances of 1,000,000 shares of the Company’s common stock for a total of 3,000,000 shares. During the first quarter of 2024, the consultant received two separate cash payments of $10,000 for a total of $20,000 and two separate issuances of 1,000,000 shares of the Company’s common stock.
CY2024Q2 snbh Liability For Subscriptions Payable
LiabilityForSubscriptionsPayable
96500 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001731122-24-001287-index-headers.html Edgar Link pending
0001731122-24-001287-index.html Edgar Link pending
0001731122-24-001287.txt Edgar Link pending
0001731122-24-001287-xbrl.zip Edgar Link pending
e5868_10q.htm Edgar Link pending
e5868_ex31-1.htm Edgar Link pending
e5868_ex31-2.htm Edgar Link pending
e5868_ex32.htm Edgar Link pending
e5868_10q_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snbh-20240630.xsd Edgar Link pending
snbh-20240630_cal.xml Edgar Link unprocessable
snbh-20240630_def.xml Edgar Link unprocessable
snbh-20240630_lab.xml Edgar Link unprocessable
snbh-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable